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J Sex MedBackground: Most studies of cervical cancer (CC) survivors describe sexual inactivity in relation to treatment
modalities, but few consider that inactivity varies with age and partner status.
Aim: The aim of this study was to investigate the prevalence of sexual inactivity in long-term CC survivors
according to age and partner status, and to examine cancer-related, health, demographic, and psychological
factors related to sexual inactivity.
Methods: All 974 women treated for CC from 2000 through 2007 in 2 areas of Norway, who were alive and
cancer-free by the end of 2013, received a mailed questionnaire. Among them, 523 delivered valid data on
current sexual activity (response rate 57%). The prevalence rates of sexual inactivity in relation to age groups and
partner status were compared to normative sample (NORMs).
Main Outcome Measure: Sexual inactivity during the 4 weeks before the survey was administered.
Results: Median age of the sample at survey was 53 years (range 32e77) and median time since diagnosis was
11 years (range 6e15). Of the survivors aged 35e69 years, 39% (95% CI 35e44%) were sexually inactive at
survey compared to 36% (95% CI 32e38%) in the NORMs. Compared with sexually active survivors, inactive
ones were significantly older, more frequently had single partner status, and had less frequently been childbearing.
Inactive survivors more frequently had low education, did not hold paid work at survey, had poorer self-rated
health, and were more often obese. They also had higher prevalence of depression, high neuroticism, and
chronic fatigue. On most cancer-related quality of life measures, sexually inactive survivors had significantly lower
mean scores than sexually active ones. They significantly more often had been treated with chemotherapy and/or
radiation than with conization or major surgery. In multivariable regression analysis, only older age, no prior
childbearing, and single partner status remained significantly associated with sexual inactivity.
Clinical implications: Sociodemographic variables may be more relevant than clinical and cancer-related vari-
ables concerning sexual inactivity in long-term CC survivors.
Strengths & Limitations: Our study had a considerable sample size and used instruments with established
psychometric qualities. The moderate response rates of the study and of the NORMs imply risks for selection
biases.
Conclusion: Close to 4 in 10 survivors were sexually inactive which is similar to the rate among NORMs.
Demographic factors were most strongly associated with sexual inactivity. Some other significant factors are
eventually amenable to treatment and should be checked by the health-care providers. Dahl AA, Bentzen AG,
Fosså SD, et al. Sexual Inactivity During the Last 4 Weeks in Long-Term Cervical Cancer Survivors:
Prevalence and Associated Factors. J Sex Med 2020;17:1359e1369.tober 7, 2019. Accepted March 22, 2020.
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Women with cervical cancer (CC) are exposed to a wide range
of treatment modalities depending on tumor stage: conization,
major surgery, radiation and chemotherapy, as well as combi-
nations of them. The ensuing treatment-related damage to the
vulvovaginal area varies considerably. Besides reproduction, sex-
ual activity is a source of excitement, intimacy with a beloved
partner, drive satisfaction, and release of emotional tension.
Therefore, lack of sexual activity can be considered as a major
sexual problem, and termination of such activity often implies
negative consequences for partnered relationship and health-
related quality of life (HRQoL) of patients who become inac-
tive.1 Many studies of CC survivors have documented high
prevalence of sexual problems, mostly relating such problems to
treatment modalities and somatic damage.2e4
Studies of the general female population in Western countries
have shown variable prevalence rates of sexual inactivity with
much increased rates in women without partners and with
increasing age.5e7 Poorer health status, obesity, physical inac-
tivity, and smoking are also significantly associated with higher
prevalence of sexual inactivity among women in the popula-
tion.5,8 Studies reporting sexual inactivity among CC survivors
usually provide a total prevalence rate without specifications
related to age groups or partner status, and several of them lack
normative control groups. To substantiate, here are 3 examples.
One uncontrolled study reported that 18% of survivors were
sexually inactive at a mean age of 52 years, 14 years after diag-
nosis, with 67% being married, 64% treated for stage I disease,
and 90% after any type of surgery. Sexual inactivity was signif-
icantly related to low income, but not to age, education, or
hysterectomy alone vs combinations with other treatment (ovary
removal, radiation, or hormones).9 Another controlled study of
51 survivors found that 31% were sexually inactive at a mean age
of 45 years, 8 years after diagnosis, with 61% being married.
Among cancer-free controls with a mean age of 41 years, and
78% being married, the inactivity rate was 20% (P ¼ .26, un-
adjusted for differences in mean age and marriage rate). In that
sample, 81% had hysterectomy and 19%
hysterectomy þ oophorectomy.10 In our own group, we reported
on 79 Norwegian survivors treated by pelvic radiotherapy, where
70% were sexually inactive at a mean age of 62 years, 8 years
after diagnosis, and 59% had a partner. In the normative control
sample, 53% were sexually inactive (P ¼ .12).11 None of these
studies presented multivariable analyses of factors related to
sexual inactivity among survivors.
On this background, our cross-sectional questionnaire study
of a cohort of Norwegian long-term CC survivors has 2 aims: (i)to explore the prevalence of sexual inactivity at the time of the
survey according to age groups and partner status and to compare
these findings to female normative sample; and (ii) in univariable
and multivariable analyses to examine the associations of medi-
cal, CC-related, demographic, health, psychological factors, and
CC-specific HRQoL in relation to sexual inactivity.METHODS
Patient Sampling
The sampling procedure has been described previously.12
Briefly, the Cancer Registry of Norway identified all women
with CC diagnosed between January 1, 2000 and December 31,
2007 and treated at hospitals located in the Health Regions of
South-Eastern and Northern Norway (3.4 million inhabitants).
This study included 974 survivors considered tumor-free and not
on any cancer treatment as of December 31, 2012. In 2015 they
were mailed a questionnaire covering cancer-related, de-
mographic, and health-related issues. The response rate was
57%, but we omitted 23 survivors who did not complete the
principal sexual activity item, and, therefore, our study sample
consisted of 523 survivors.
Treatment for CC in Norway 2000e2007
The treatment alternatives have also been described previ-
ously.12 Women with minimal disease (International Federation
of Gynecology and Obstetrics [FIGO] stage Ia) were treated with
conization (conization group). Patients with disease of limited
volume (FIGO stage IbeIIa) usually had radical hysterectomy
with pelvic lymph node dissection with or without bilateral
salpingo-oophorectomy (major surgery group). Patients with
locally advanced disease (FIGO stage IIbeIVa) were treated by
external-beam pelvic radiation to the tumor and the regional
lymph nodes, combined with intracavitary brachytherapy (che-
moradiotherapy group).13 In addition, low-dose cisplatin-con-
taining chemotherapy was given concomitantly to enhance the
efficacy of the radiation.14 Another group either received neo-
adjuvant chemotherapy followed by major surgery, or had other
combinations of major surgery and external beam pelvic radia-
tion along with chemotherapy (major
surgery þ chemoradiotherapy group).
Main Outcome measure: Sexual Inactivity
The Current Sample
Item #19 of The European Organization for Research and
Treatment of Cancer Quality-of-Life Questionnaire-CX24:
“Have you been sexually active during the past 4 weeks?”J Sex Med 2020;17:1359e1369





(N ¼ 309) P-value
Total sample
(N ¼ 523)
Age at diagnosis (years), median (range) 46 (26e68) 39 (24e68) <.001 41 (24e68)
Time diagnosis to survey, median (range) 11 (6e15) 11 (7e15) .13 11 (6e15)
Treatment modalities, N (%)
Any radiotherapy 89 (42) 65 (21) <.001 154 (29)
External radiotherapy 86 (40) 63 (20) <.001 149 (29)
Brachytherapy 70 (33) 42 (14) <.001 102 (21)
Relapse, N (%) 21 (10) 22 (7) .12* 43 (8)
Another cancer, N (%) 24 (11) 16 (5) .10* 40 (8)
Current HRT use, N (%) 42 (20) 74 (24) .31* 117 (22)
Age at survey (years), median (range) 57 (36e76) 50 (32e77) <.001 53 (32e77)
Level of education, N (%)
12 years 73 (34) 155 (50) .022* 228 (44)
>12 years 139 (66) 152 (50) 291 (56)
Partner status, N (%)
Married, living together 116 (55) 246 (80) <.001* 362 (70)
Single, widow, divorced 97 (45) 62 (20) 159 (30)
Childbearing, N (%) 105 (49) 194 (63) .002* 299 (57)
Income status at survey, N (%) <.001
Paid work 112 (53) 225 (73) <.001 337 (65)
Disability pension 37 (17) 40 (13) .17 77 (15)
Retirement pension 47 (22) 25 (8) <.001 72 (13)
Other statuses 17 (8) 18 (6) .38 35 (7)
Work ability at survey, mean (SD) 6.0 (3.5) 7.5 (3.3) <.001* 6.9 (3.4)
Charlson's comorbidity index, N (%) .07*
0 points 116 (54) 212 (69) 328 (63)
1 point 71 (33) 25 (24) 146 (28)
2 points 27 (13) 22 (7) 49 (9)
Current self-rated health, N (%) <.001*
Excellent to good 136 (64) 249 (81) 386 (74)
Moderate to poor 76 (36) 59 (19) 135 (26)
Obesity, N (%) 45 (22) 37 (12) .005* 82 (16)
Daily smoking, N (%) 49 (24) 54 (18) .22* 103 (20)
HADS-anxiety sum score 8, N (%) 86 (40) 112 (36) .20* 198 (38)
PHQ-9 depression sum score 10, N (%) 58 (27) 41 (13) <.001* 99 (19)
Chronic fatigue, N (%) 85 (31) 64 (21) .002* 129 (25)
Neuroticism score 3 points, N (%) 97 (46) 108 (35) .01* 205 (40)
Changed sexual function, N (%) 59 (28) 70 (23) .21 129 (25)
HADS ¼ Hospital Anxiety and Depression Scale; HRT ¼ hormone replacement treatment; PHQ ¼ Patient Health Questionnaire.
Significant P values are set in bold types.
*Adjusted for age at survey.
Characterstics of Long-Term Cervical Cancer Survivors 1361represented the principal sexual variable, and there were 4
response alternatives: 1 (“not at all”), 2 (“a little”), 3 (“quite a
bit”), and 4 (“very much”). The responses were dichotomized so
that survivors who reported “not at all” were defined as “sexually
inactive,” while those who reported “a little” or more were
classified as “sexually active.”15
The Normative Sample (NORMs)
The Sexual Activity Questionnaire (SAQ)7 includes the item:
“Do you engage in sexual activity with anyone now?” with the
response alternatives “yes” or “no.” Women who responded withJ Sex Med 2020;17:1359e1369“no” were considered as sexually inactive. The NORMs was
based on a target population of 2,800 Norwegian women aged
20e69 years who received a mailed questionnaire. Among them
1,165 (42%) returned a valid questionnaire. We have previously
published the SAQ findings from this sample, and the age groups
35e44, 45e55, and 56e69 years and their total were relevant
for comparisons with our survivors' sample.7 For this study, we
divided the NORMs age groups into women with a partner vs
those without one (Table 2).
It is important to note that neither the CX24 nor the SAQ
item specifies the relevant sexual activity further. Anything











CCSs 32/109 (29.4)* 64/189 (33.9) 87/168 (51.8) 183/466 (39.3)
NORMs 35/213 (16.4) 78/283 (27.6) 214/405 (52.8) 327/901 (36.3)
Women with partner
CCSs 20/85 (23.5)* 34/125 (27.2) 48/117 (41.0) 102/327 (31.2)
NORMs 23/198 (11.6) 36/235 (15.5) 107/296 (36.1) 166/729 (22.8)
Women without partner
CCSs 12/24 (50.0) 29/62 (46.8)* 39/51 (76.5)* 80/137 (58.4)*
NORMs 12/15 (80.0) 42/48 (87.5) 107/109 (98.2) 161/172 (93.6)
CCSs
With partner 20/85 (23.5)* 34/125 (27.2)* 48/117 (41.0)* 102/327 (31.2)*
Without partner 12/24 (50.0) 29/62 (46.8) 39/51 (76.5) 80/137 (58.4)
NORMs
With partner 23/198 (11.6)* 36/235 (15.5)* 107/296 (36.1)* 166/729 (22.8)*
Without partner 12/15 (80.0) 42/48 (87.5) 107/109 (98.2) 161/172 (93.4)
CCSs ¼ cervical cancer survivors; NORMs ¼ normative sample.
Significant P values are set in bold types.
*Vertical comparisons P < .05.
1362 Dahl et alconsidered as sexual activity by the respondents could be performed
alone as well as with one or more partners. We could not further
specify types of sexual activity. Since the CX24 item specifies the
time frame of 4weeks, while the SAQ item seems to imply just at the
time when the survivors completed the questionnaire, our defini-
tions of sexual inactivity and activity concerned the last 4 weeks
before the time of the survivors' response to the survey.Scales
All the scales used in this study had tested psychometric
properties concerning reliability and validity.
CC-specific HRQoL (European Organization for Research and
Treatment of Cancer CX24)—the CX24 consists of 24 items that
for all survivors could be reported as 2 scales (symptom experi-
ence and body image) and 4 single items (lymphedema, pe-
ripheral neuropathy, menopausal symptoms, and sexual worry).
5 items (#50e54) are only relevant for sexually active survivors
with the sexual/vaginal function scale, and the sexual enjoyment
item. For the analyses, all subscale scores and single item ratings
were transformed to 0e100, where higher scores on the scales
and on single items represented higher symptom intensity.15 For
the subscales, Cronbach's coefficient alpha was 0.67 for symp-
tom experiences, 0.86 for body image, and 0.78 for sexual/
vaginal functioning. The Fatigue Questionnaire measured fatigue
severity and included items concerning mental (4 items) and
physical fatigue (7 items), and their sum (total fatigue) for the
last 4 weeks. Each item was rated from 0 (“as before”) to 3 (“very
much worse”). An additional item covered the duration of the
fatigue experience with one response alternative being “6 months
or more.”16 Concerning chronic fatigue, a dichotomized score
for each response alternative (0 ¼ 0, 1 ¼ 0, 2 ¼ 1, 3 ¼ 1) wasused, and chronic fatigue was defined as a dichotomized sum
score of 4 with a duration of 6 months. Alpha was 0.90 for
total fatigue.
The Hospital Anxiety and Depression Scale comprised 7 items
each on the anxiety and depression subscales rated for last week.
The item scores ranged from 0 (“not present”) to 3 (“highly
present”), providing a 0e21 severity score. Only the anxiety
subscale was adopted, and alpha was 0.66. A probable case of
anxiety disorder had a sum score 8.17
The Patient Health Questionnaire-9 contained 9 items covering
depression for the last 2 weeks, and each item was scored from
0 (“not at all”) to 3 (“nearly every day”), providing a 0e27
severity score. A probable case of major depressive episode had a
sum score 10. Alpha was 0.87.18
Current work ability was compared to the lifetime best on a
continuous 10 points Numerical Rating Scale from 0 (“currently
not able to do work”) to 10 (“work ability as previous life-time
best”) from the Work Ability Index instrument.19,20 Neuroti-
cism was self-rated on an abridged version of the Eysenck Per-
sonality Questionnaire with 6 items concerning long-term
personality characteristics. Each item was rated as 1 (“present”)
or 0 (“absent”). The sum score ranged from 0 to 6 and was
dichotomized into high (sum score 3e6) and low neuroticism
(sum score 0e2) groups according to the use in the third Health
Study of North-Trøndelag County (The HUNT-3 study).21Other Variables
Sociodemographic
Partner status was dichotomized as married or living together
(with partner) vs single, divorced, or widow (without partner).J Sex Med 2020;17:1359e1369
Characterstics of Long-Term Cervical Cancer Survivors 1363Having had children was rated as yes or no. Level of education was
dichotomized into low (12 years) and high (>12 years). Income
status at the time when the survey was administered was classified as
paid work, disability pension, retirement pension, or other statuses.
Comorbidity was based on self-report of diseases described in
the Charlson's Comorbidity Index22 where myocardial infarc-
tion, congestive heart failure, stroke, diabetes, chronic obstruc-
tive lung diseases, ulcer disease, connective tissue diseases all get 1
point, and kidney disease 2 points. We defined 3 comorbidity
groups: none (0), 1, and 2 points.
Self-rated health was dichotomized according to response al-
ternatives into good (“excellent”/“very good”/“good”) and poor
(“fair”/“poor”). Lifestyle issues included smoking any number of
cigarettes daily. Obesity was defined as a body mass index 30.
Experience of changed sexual function or not after treatment for
CC was recorded as yes or no. Current use of hormone
replacement treatment (HRT) was noted, but no other infor-
mation concerning medication was collected.Statistical Evaluation
Group comparisons of continuous variables were carried out
with t-tests, and in case of skewed distributions Mann-Whitney
U tests were used. Comparisons of categorical variables were
performed with chi-square tests. Since the sexually inactive group
showed significantly higher median age compared to the active
group, age-related group comparisons were adjusted for age at the
time the survey was administered. The internal consistencies of
scales were examined with Cronbach's coefficient alpha. Associ-
ations between independent variables and sexual inactivity vs
sexual activity (reference) as the dependent variable were exam-
ined with univariate and multivariable logistic regression ana-
lyses. The strength of associations was expressed as odds ratios
with 95% CI as appropriate. Variables included in the multi-
variable analysis were tested for multicollinearity, which only was
present for work-related variables. The P-value was set as <.05,
and all tests were 2-sided. The statistical software applied was
SPSS version 25 for PC (IBM Corporation, Armonk, New York,
USA).Ethical Considerations
The Regional Committee for Medical and Health Research
Ethics of South-Eastern Norway has approved the study. All
survivors gave written informed consent when returning their
questionnaires. They were not economically compensated.RESULTS
Description of the Total Sample
The median age at diagnosis was 41 (range 24e68) years,
median age at survey was 53 (range 33e77) years, and median
time from diagnosis to survey 11 (range 6e15) years. Further,
characteristics of the total sample are displayed in Table 1. Of the
total sample, 41% (95% CI 37e45%) of survivors reportedJ Sex Med 2020;17:1359e1369sexual inactivity and 59% (95% CI 55e63%) reported sexual
inactivity during the last 4 weeks. In all 25% reported changed
sexual function after their treatment for CC, implicating that
75% of survivors had unchanged sexual function. The prevalence
of sexual inactivity was 26% in the conization group, 35% in the
major surgery group, 62% in the chemoradiotherapy group, and
49% in the major surgery þ chemoradiotherapy group. Only the
latter 2 treatment groups differed significantly from the NORMs
prevalence concerning sexual inactivity (P < .001 and P ¼ .012,
respectively). Among sexually inactive survivors, 42% had any
form of radiotherapy, while that proportion was 21% among
sexually active survivors (P < .001). HRT was used by 22% of
the total sample at the time of the survey.Comparisons with NORMs
The prevalence of sexual inactivity among the total sample of
survivors aged 35e69 years was 39% (95% CI 35e44%), while
among NORMs of the same age group 36% (95% CI 32e38%)
were inactive (P ¼ .32) (Table 2). For the 35e44 years group,
the prevalence rates of sexual inactivity were significantly higher
than NORMs for all survivors and for survivors with a partner.
Survivors without a partner had significantly lower prevalence
of sexual inactivity in the 45e55 and 56e69 years age groups
and the total group compared to NORMs. Both for survivors
and for NORMs the prevalence of sexual inactivity increased
with older age. All age groups of survivors without a partner had
significantly higher prevalence of sexual inactivity than those
with a partner. The same prevalence pattern was found among
NORMs.Comparisons of the Sexually Inactive and Active
Survivor Groups
Median age at survey of the inactive group was 57 years vs
50 years in the active group (P < .001). Consequently, age-
related between-group comparisons were adjusted for age at
the time of the survey in Table 1. Figure 1 shows that the
inactive group had significantly more chemoradiotherapy treat-
ment and significantly less conization than the sexually active
group.
Table 1 further shows that among the sexually inactive sur-
vivors significantly more were unmarried, divorced, or widows,
and a lower proportion had given birth than among sexually
active survivors. At the time of the survey, significantly fewer of
the inactive group were in paid work, and they had significantly
lower mean work ability compared to the sexually active group.
No significant between-group differences were observed con-
cerning comorbidity or the current use of HRT, while a higher
proportion among those sexually inactive reported fair or poor
self-rated health. Obesity was significantly more common in the
inactive group, and survivors belonging to that group reported
higher prevalence rates of depression, chronic fatigue, and high
neuroticism. For CC-specific HRQoL (CX24), the sexually















Figure 1. Percent of sexually inactive and active survivors according to treatment group. Significant between-group differences for
conization (P < .001) and chemoradiotherapy (P < .001). Figure 1 is available in color online at www.jsm.jsexmed.org.
1364 Dahl et alin the abdomen, swelling of the leg(s), and low back pain than
the active group (Table 3). In addition, they felt less attractive
and feminine, were more dissatisfied with their bodies, and more
frequently worried that sex would be painful than the sexually
active survivors. The mean scores on body image and lymphe-
dema were significantly worse in the inactive than in the sexually
active group (Table 3). Among the sexually active survivors, 73%
found sex enjoyable.Bivariate and Multivariable Regression Analyses
In the bivariate analyses, significant between-group differences
were observed within the CC-related, demographic, health and
lifestyle, psychological, and HRQoL domains (Table 4). In the
multivariable analysis, only the demographic variables remained
significantly associated with being a sexually inactive survivor:
older age, having single civil status, and less frequently had
children.DISCUSSION
In our sample of long-term CC survivors diagnosed and
treated for CC at a median of 11 years earlier, 41% (age range
33e77 years) reported that they had been sexually inactive
during the last 4 weeks. For the 35e69 years age group, the
prevalence among survivors was 39% and did not differ signifi-
cantly from the 36% reported by NORMs. For both survivors
and NORMs, the rate of sexual inactivity increased with age.
The survivors with partners had a significantly higher rate of
sexual inactivity compared to NORMs for the 35e44 year
group, but with similar rates for NORMs and survivors in the
older age groups. Survivors without a partner had a significantly
lower rate of sexual inactivity than NORMs for the 45e55 and
56e69 year groups. These latter findings are counterintuitive,and they concern the sampling bias of the NORMs covered in
the Strengths and Limitations section.
Among the survivors, sexual inactivity was significantly asso-
ciated with cancer-related, demographic, self-reported health,
psychological factors, and CC-specific HRQoL in the bivariate
analyses. However, only 3 demographic variables remained
significantly associated with sexual inactivity in the multivariable
analysis: older age, no partner status, and no childbearing. Fac-
tors like overall treatment modalities, self-rated health, fatigue, or
mental distress showed weaker associations with sexual inactivity
among survivors.
Only 25% of survivors reported change of sexual function
after treatment with no significant differences between active and
inactive survivors. This finding indicates that sexual function
established before the CC and its treatment continues later in
most of the survivors. A Danish sample treated with only
radiotherapy reported that 63% of those who were sexually active
before treatment remained active but with less frequency at
12 months after treatment.23
Our findings of similar overall rates of sexual inactivity in
survivors and normative control samples are in line with some
previous studies,7,24,25 but these studies do not specify age
groups like we do. We observed that the prevalence of sexual
inactivity among survivors was significantly higher than for
NORMs in the age group 35e44 and 45e55 years. For the
56e69 years group, the prevalence was similar, most probably
due to the increasing rate of sexual inactivity reported by older
women in general.5,6 Sexual inactivity before the age of 55 years
is more common among survivors than NORMs and may
represent a clinical problem for them.
Like previous studies we observed that the chemoradiotherapy
group was significantly associated with sexual inactivity. This
could be due to the associated prevalence of chronic fatigue asJ Sex Med 2020;17:1359e1369












Cramps in the abdomen 24 (11) 19 (6) .019* 43 (8)
Difficult bowel control 26 (12) 19 (6) .052* 45 (9)
Bloody stools 4 (2) 7 (2) .32* 11 (2)
Frequent urination 84 (40) 92 (30) .052* 176 (34)
Pain/burning when urinating 4 (2) 15 (5) .69* 19 (4)
Leaking urine 37 (18) 41 (13) .66* 78 (15)
Difficulty emptying bladder 31 (15) 30 (10) .22* 61 (12)
Swelling of leg(s) 65 (31) 60 (20) .006* 125 (24)
Lower back pain 81 (38) 80 (26) .020* 161 (31)
Numbness/tingling hands or feet 55 (26) 71 (23) .23* 126 (24)
Irritation/soreness vulva or vagina 19 (9) 27 (9) .89* 46 (9)
Discharge from vagina 10 (5) 21 (7) .06* 31 (6)
Abnormal vaginal bleeding 1 (0.5) 4 (1) .28* 5 (1)
Hot flushes and/or sweats 47 (22) 71 (24) .78* 118 (23)
Felt physically less attractive 51 (24) 43 (14) <.001* 94 (18)
Felt less feminine 36 (17) 36 (12) .008* 72 (14)
Dissatisfied with your body 64 (30) 58 (19) .001* 122 (24)
Worried that sex would be painful 46 (22) 35 (11) .001* 81 (16)
EORTC CX24 HRQoL, mean (SD)
Symptom experience 17.1 (12.2) 15.1 (12.5) .15* 16.1 (12.3)
Body image 27.7 (27.8) 20.5 (24.1) <.001* 23.8 (26.0)
Lymphedema 34.1 (35.7) 25.6 (34.2) .014* 29.2 (35.1)
Peripheral neuropathy 31.3 (33.7) 26.5 (31.6) .24* 28.5 (32.6)
Menopausal symptoms 27.7 (35.8) 27.9 (31.6) .74* 28.0 (33.4)
Sexual worry 23.2 (33.9) 13.9 (25.3) .001* 17.9 (29.6)
For sexually active CCSs, N (%)
Vagina dry during sexual activity - 50 (16) - -
Vagina felt short - 34 (11) - -
Vagina felt tight - 16 (5) - -
Pain during sexual activity - 33 (11) - -
Sexual activity enjoyable - 225 (73) - -
Vaginal/sexual functioning, mean (SD) - 18.6 (20.9) - -
EORTC ¼ European Organization for Research and Treatment of Cancer; CCSs ¼ cervical cancer survivors; HRQoL ¼ health-related quality of life.
Significant P values are set in bold types.
*Adjusted for age at survey.
Characterstics of Long-Term Cervical Cancer Survivors 1365well as physical changes, which are frequent after this treatment
modality.26 In contrast to some other studies,4 we observed no
significant association between major surgery (radical hysterec-
tomy with pelvic lymph node dissection with or without bilateral
salpingo-oophorectomy) and sexual inactivity. Other aspects like
relapse of CC or the occurrence of another cancer showed no
significant associations with sexual inactivity.
The occurrence of sexual inactivity in CC survivors was most
strongly associated with demographic factors in the multivari-
able analysis. The association with older age is in line with
findings from the general female population.5,6 Having single
civil status (never married, divorced, or widow), as well as never
having given birth, may indicate the lack of suitable sexual
partners. In the general population, lack of partner is the mostJ Sex Med 2020;17:1359e1369frequent reason given by women for sexual inactivity.7 From
studies of the general population, we know that women with a
low level of education report more sexual inactivity,6 and this
finding was confirmed in our bivariate analyses. However, that
result did not remain significant in the multivariable analysis.
Somatic issues are of clinical relevance since some of them can
be identified and treated. Obesity, abdominal cramps, low back
pain, and lymphedema are such concerns which were signifi-
cantly more prevalent among sexually inactive survivors, as was
moderate to poor self-rated health. Increasing number of
comorbidities remained borderline significant in the sexually
inactive group. Regular somatic workups by their general
practitioners, therefore, could be of relevance for sexually
inactive CC survivors.
Table 4. Logistic regression analyses of independent variables and being sexually inactive (N ¼ 214) and sexually active (N ¼ 309)
(reference) at survey
Variables
Bivariate analyses Multivariable analysis
OR 95% CI P OR 95% CI P
Older age at survey 1.06 1.04e1.08 <.001 1.06 1.03e1.09 <.001
Low level of education 1.94 1.35e2.79 <.001 1.42 0.91e2.17 .12
Single civil status 3.31 2.25e4.89 <.001 3.42 2.17e5.38 <.001
Had children 0.57 0.40e0.81 .002 0.56 0.36e0.87 .009
Not paid work at survey 1.17 1.10e1.24 <.001 MC
Work ability at survey 0.88 0.84e0.93 <.001 1.04 0.96e1.14 .34
Treatment modalities <.001 0.16
Conization (reference) 1.00 - - 1.00 - -
Major surgery 1.57 0.94e2.64 .09 0.98 0.54e1.79 .95
Chemoradiotherapy 4.76 2.63e8.62 <.001 1.92 0.92e4.01 .08
Surgery þ chemoradiotherapy 2.81 1.49e5.30 .001 1.32 0.61e2.86 .48
Current self-rated health 2.36 1.58e3.52 <.001 1.66 0.89e3.08 .11
Obesity 1.97 1.22e3.17 .005 1.37 0.75e2.51 .31
High neuroticism 1.58 1.11e2.26 .012 MC - -
Chronic fatigue 1.71 1.14e2.55 .009 MC - -
PHQ-9 depression 2.44 1.56e3.82 <.001 1.63 0.89e2.98 .12
EORTC CX24 HRQoL
Symptom experience 1.01 1.00e1.03 .08 - - -
Body image 1.01 1.00e1.02 .002 1.01 1.00e1.02 .31
Lymphedema 1.01 1.00e1.01 .007 1.00e1.01 .46
Abdominal cramps 1.24 0.96e1.61 .10 1.00 0.88e1.41 .36
Low back pain 1.22 1.07e1.31 .006 1.11
HRQoL ¼ health-related quality of life; OR ¼ odds ratio; PHQ ¼ Patient Health Questionnaire.
MC: Excluded from the multivariable analyses due to multicollinearity with not being in paid work.
Significant P values are set in bold types.
1366 Dahl et alAmong psychological variables, the prevalence of chronic fa-
tigue and depression as well as problems with femininity and
body image were more common among sexually inactive survi-
vors. Both fatigue and depression are well-known risk factors for
sexual inactivity,27 but depression is more amenable to treatment
than fatigue.
Interestingly, the CX24 symptom experience scale mean score
covering bowel, urinary, and vulvar/vaginal symptoms did not
show significant between-group differences. This finding in-
dicates that local pelvic symptoms are not significantly associated
with sexual inactivity in the total group of survivors.
Strengths and Limitations
An advantage of our study is the considerable sample size
giving enough statistical power to the subgroup analyses of
sexually inactive survivors in contrast to some previous
studies. Our grouping according to age and partner status
should be considered as progress compared to previous studies
of sexual inactivity among survivors. We also included cancer-
related, demographic, health, psychological factors, and
HRQoL variables taking a broad approach to the sexual
inactivity problem in survivors. Another strength is our use of
well-established self-rating instruments with tested psycho-
metric properties.Our response rate of 57% at a mean of 11 years post diagnosis
must also be considered as acceptable. However, the lack of data
for an attrition analysis trying to characterize the non-
respondents further must be considered a weakness. This issue
raises the problem of the representativity of our sample, which
also could be raised concerning the NORMs we used.7 Partic-
ularly, the very high rates of sexual inactivity among NORMs
without a partner should raise concern about response bias.
Perhaps women without partners are more concerned about their
sexuality, and therefore they more likely report and complete
studies. We have also presented the comparisons of sexual
inactivity rates between survivors and NORMs despite some
minor differences in the definitions of the SAQ and CX24.
Another limitation is the lack of prospectively collected data
including the pre-diagnostic prevalence of sexual inactivity in our
sample of survivors. Since we only have cross-sectional data, we
present significant associations between variables, rather than
causal findings. Another weakness is the lack of data on specific
sexual dysfunctions.
Finally, sexual inactivity is challenging to study mainly due to
lack of proper instruments. For example, our questionnaires (the
SAQ for NORMs and the CX24 for survivors) do not specify if
masturbation shall be included or not when the respondents
consider sexual activity. Our instruments also do not clearlyJ Sex Med 2020;17:1359e1369
Table 5. Prevalence rates of sexual inactivity and other relevant variables in samples of cervical cancer survivors
Study Sexually inactive cervical cancer survivors (%) Other variables (%)
Current study 35e44 years 45e55 years 56e69 years All women Living with partner All controls Surgery only Time since diagnosis*
Norway
All women 29.4 33.9 51.8 39.3 35.9 46.1 11.0
Living with partner 23.5 27.2 41.0 31.2 69.2 22.8
Not living with partner 50.0 46.8 76.5 58.4 - 93.6
Cull et al (1993)24
Scotland
All women - - - 26.5 75.9 - 55.4 1.9
Bergmark et al (1999)25
Sweden
All women - - - 30 64.5 30 89.5 6
Jensen et al (2003)23
Denmark
All women - - - 10.8 85.0 14.9 100 2.0
Wenzel et al (2005)10
United States
All women - - - 31.0 60.8 20.0 63.0 8.0
Donovan et al (2007)29
United States
All women - - - 10 66 4 64 3.0
Tangjitgamol et al (2007)30
Thailand
All women 7.6 - - 91.8 1.7
Greenwald et al (2008)9
United States
All women - - - 18.9 67.0 - 89.9 13.9
Greimel et al (2009)31
Austria
All women - - - 43.0 39.0 - 52.1 9.0
Jensen et al (2004)28
Denmark
All women - - - 47.0 64.0 26.0 0 1.0



















1368 Dahl et alseparate sexual activity with and without a partner, and this is a
source of error in many studies of CC survivors. Another
problem is the time frame concerning sexual inactivity. The SAQ
states “at the moment of questionnaire completion,”7 while the
CX24 specifies the last 4 weeks.15 Other studies of sexual inac-
tivity among CC survivors (Table 5) hardly have any time
specifications.9,10,23e31
The next problem is the use of interview vs questionnaire for
data collection. Both modalities have advantages and drawbacks.
Sensitive sexual information could be easier to admit on a
questionnaire than by an interview. On the other hand, unclear
responses are perhaps more easily given in questionnaires than in
interviews. Population studies of sexual functioning generally use
interviews,5,6 as opposed to studies of CC survivors where
questionnaires are more common.9,10,23e31 Another problem is
that results on sexual inactivity in survivors rarely are reported by
age groups and partner status (Table 5), thereby being less
meaningful and hard to interpret. The problem of comparing the
sexual inactivity rates of various studies also is complicated due to
variation in treatment types and mean follow-up time (Table 5).
Finally, the response bias problems of both CC survivors and
population samples should be specified, and preferably adjusted
for by statistical weighting procedures.CONCLUSIONS
Close to 4 in 10 CC survivors were sexually inactive at the
time the survey was administered, which is similar to the prev-
alence among normative females of the same age. Demographic
factors were most strongly associated with sexual inactivity. Some
other significantly associated factors are amenable to identifica-
tion and possible treatment that calls for an active attitude of
health-care providers.
Corresponding Author: Alv A. Dahl, MD, PhD, National
Advisory Unit for Late Effects After Cancer, Oslo University
Hospital, The Norwegian Radium Hospital, P.O. Box 4953,
Nydalen, 0424, Oslo, Norway. Tel: 0047-22934000; Fax:
22934553; E-mail: a.a.dahl@ibv.uio.no
Conflict of Interest: The authors report no conflicts of interest.
Funding: This study was funded by the Norwegian Cancer So-
ciety (grant #45980).STATEMENT OF AUTHORSHIP
Category 1
(a) Conception and Design
Rita Steen; Anne Gry Bentzen; Sophie D. Fosså; Cecilie E.
Kiserud(b) Acquisition of Data
Anne Gry Bentzen; Siri Lothe Hess; Rita Steen(c) Analysis and Interpretation of Data
Alv A. Dahl; Sophie D. Fosså; Cecilie E. KiserudCategory 2
(a) Drafting the Article
Alv A. Dahl; Anne Gry Bentzen; Sophie D. Fosså; Rita Steen;
Ingvild Vistad; Cecilie E. Kiserud(b) Revising It for Intellectual Content
Anne Gry Bentzen; Siri Lothe Hess; Rita Steen; Ingvild VistadCategory 3
(a) Final Approval of the Completed Article
Alv A. Dahl; Anne Gry Bentzen; Sophie D. Fosså; Siri Lothe
Hess; Rita Steen; Ingvild Vistad; Cecilie E. KiserudREFERENCES
1. Lehmiller JJ. The Psychology of Human Sexuality. Chichester,
UK: Wiley Blackwell; 2014.
2. Lammerink EAG, de Bock GH, Pras E, et al. Sexual functioning
in cervical cancer survivors: A review with a female perspec-
tive. Maturitas 2012;72:296-304.
3. Ye S, Yang J, Cao D, et al. A systematic review of quality of life
and sexual function of patients with cervical cancer after
treatment. Int J Gynecol Cancer 2014;24:1146-1157.
4. Vrzacova P, Weiss P, Cibula D. Sexual morbidity following
radical hysterectomy for cervical cancer. Expert Rev Anti-
cancer Ther 2010;10:1037-1042.
5. Lindau ST, Gavrilova N. Sex, health, and years of sexually
active life gained due to good health: evidence from two US
population based cross sectional surveys of ageing. BMJ
2010;340:c810.
6. Mitchell KR, Mercer CH, Ploubidis GB, et al. Sexual function in
Britain: findings from the third National Survey of Sexual
Attitudes and Lifestyle (Natsal 3). Lancet 2013;382:1817-
1829.
7. Vistad I, Fosså SD, Kristensen GB, et al. The Sexual Activity
Questionnaire: Psychometric properties and normative data in
a Norwegian population sample. J Women’s Health 2007;
16:139-148.
8. Christensen BS, Grønbæk M, Pedersen BV, et al. Associations
of unhealthy lifestyle factors with sexual inactivity and sexual
dysfunctions in Denmark. J Sex Med 2011;8:1903-1916.
9. Greenwald HP, McCorkle R. Sexuality and sexual function in
long-term survivors of cervical cancer. J Women’s Health
2008;17:955-963.
10. Wenzel L, DeAlba I, Habbal R, et al. Quality of life in long-term
cervical cancer survivors. Gynecol Oncol 2005;97:310-317.
11. Vistad I, Fossa S, Kristensen G, et al. Chronic fatigue and its
correlates in long-term survivors of cervical cancer treated
with radiotherapy. BJOG 2007;114:1150-1158.
12. Steen R, Dahl AA, Hess SL, et al. A study of chronic fatigue in
Norwegian cervical cancer survivors. Gynecol Oncol 2017;
146:630-635.
13. Keys H, Gibbons SK. Optimal management of locally advanced
cervical carcinoma. J Natl Cancer Inst Monogr 1996;21:89-92.
14. Green JA, Kirwan JM,Tierney JF, et al. Survival and recurrence
after concomitant chemotherapy and radiotherapy for cancerJ Sex Med 2020;17:1359e1369
Characterstics of Long-Term Cervical Cancer Survivors 1369of the uterine cervix: a systematic review and meta-analysis.
Lancet 2001;358:781-786.
15. Greimel ER, Vlasic KK, Duric VM, et al. The European Orga-
nization for Research and Treatment of Cancer (EORTC)
Quality-of-Life Questionnaire Cervical Cancer Module. Cancer
2006;107:1812-1822.
16. Chalder T, Berelowitz G, Pawlikowska T, et al. Development of
a fatigue scale. J Psychosom Res 1993;37:147-153.
17. Bjelland I, Dahl AA, Haug TT, et al. The validity of the Hospital
Anxiety and Depression Scale. An updated literature review.
J Psychosom Res 2002;52:69-77.
18. Kroenke K, Spitzer RL,Williams JBW.The PHQ-9: Validity of a
brief depression severity measure. J Intern Med 2001;
16:606-613.
19. Tuomi K, Ilmarinen J, Jakhola A, et al. Work Ability Index. 2nd
edition. Helsinki: Finnish Institute of Occupational Health;
2006.
20. Ahlstrom L, Grimby-Ekman A, Hagberg M, et al. The work
ability index and single- question: associations with sick leave,
symptoms, and health e a prospective study of women on
long-term sick leave. Scand J Work Environ Health 2010;
36:404-412.
21. Grav S, Stordal E, Romild UK, et al. The relationship between
neuroticism, extraversion, and depression in the HUNT study:
in relation to age and gender. Issues Ment Health Nurs 2012;
33:777-785.
22. Charlson ME, Pompei P, Ales K, et al. A new method of
classifying prognostic comorbidity in longitudinal studies:
development and validation. J Chron Dis 1987;40:373-383.J Sex Med 2020;17:1359e136923. Jensen PT, Groenvold M, Klee MC, et al. Longitudinal study of
sexual function and vaginal changes after radiotherapy for
cervical cancer. Int J Radiat Oncol Biol Phys 2003;56:937-
949.
24. Cull A, Cowie VJ, Farquharson DIM, et al. Early stage cervical
cancer: psychosocial and sexual outcomes of treatment. Br J
Cancer 1993;68:1216-1220.
25. Bergmark K, Åvall-Lundqvist E, Dickman PW, et al. Vaginal
changes and sexuality in women with a history of cervical
cancer. N Engl J Med 1999;340:1383-1389.
26. Ripamonti CI, Antonuzzo A, Bossi P, et al. Fatigue, a major still
underestimated issue. Curr Opin Oncol 2018;30:219-225.
27. McCabe MP, Sharlip ID, Lewis R, et al. Risk factors for sexual
dysfunction among women and men: A consensus statement
from the Fourth International Consultation on Sexual Medicine
2015. J Sex Med 2016;13:153-167.
28. Jensen PT, Groenvold M, Klee MC, et al. Early stage cervical
carcinoma, radical hysterectomy, and sexual function. Cancer
2004;100:97-106.
29. Donovan KA, Taliaferro LA, Alvarez EM, et al. Sexual health in
women treated for cervical cancer: Characteristics and corre-
lates. Gynecol Oncol 2007;104:428-434.
30. Tangjitgamol S, Manusirivithaya S, Hanprasertpong J, et al.
Sexual dysfunction in Thai women with early-stage cervical
cancer after hysterectomy. Int J Gynecol Cancer 2007;
17:1104-1112.
31. Greimel ER, Winter R, Kapp KS, et al. Quality of life and sexual
functioning after cervical cancer treatment: a log-term follow-
up study. Psycho-Oncol 2009;18:476-482.
